1-4 of 4
Keywords: 5α–reductase inhibitors
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 39 (4): 390–399.
Published Online: 02 April 2001
.... Benign prostatic hyperplasia Progression Dihydrotestosterone Reductase inhibitors Benign prostatic hyperplasia (BPH) is a common condition in older men and the prevalence, and thus the burden on healthcare resources, is set to increase with the ageing population. Although controversy exists...
Journal Articles
Subject Area:
Further Areas
European Urology (2000) 38 (1): 2–19.
Published Online: 07 June 2000
.... Benign prostatic hyperplasia α–Adrenergic antagonists Reductase inhibitors European Urology Review Eur Urol 2000;38:2 19 Accepted after revision: October 27, 1999 Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature G.M. Clifford, R.D.T. Farmer Public Health and Primary...
Journal Articles
Subject Area:
Further Areas
European Urology (2000) 37 (4): 367–380.
Published Online: 17 March 2000
... is a reductase inhibitor that has been used for the treatment of benign prostatic hyperplasia and male–pattern baldness. At doses used clinically, its major effect is through suppression of type 2 5α–reductase, because it has a much lower affinity for the type 1 isoenzyme. Finasteride suppresses DHT...
Journal Articles
Subject Area:
Further Areas
European Urology (1998) 34 (3): 169–175.
Published Online: 02 September 1998
...F.M.J. Debruyne; A. Jardin; D. Colloi; L. Resel; W.P.J. Witjes; M.C. Delauche-Cavallier; C. McCarthy; C. Geffriaud-Ricouard Objectives: To assess the additive benefit of combining an α 1 -blocker and a -reductase inhibitor. Methods: This European, randomized, double-blind, multicenter trial...